Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a qualitative study of the impact on attitudes and beliefs
- PMID: 27913558
- PMCID: PMC5168685
- DOI: 10.1136/bmjopen-2016-012000
Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a qualitative study of the impact on attitudes and beliefs
Abstract
Objective: To explore the impact of providing additional information about the potential benefits of simvastatin in a patient leaflet on attitudes and beliefs.
Design: Interview-based study using a generic qualitative approach and framework analysis.
Participants: 21 participants receiving a prescription for simvastatin were recruited from a general practitioner practice (from a total of 120). 8 participants were women; the age range was 55-92.
Intervention: Participants were provided with leaflets showing one of 3 types of additional benefit information: (1) textual statement, (2) number needed to treat (NNT) or (3) natural frequency. Semistructured interviews explored patient's attitudes and beliefs.
Results: A descriptive narrative of preferences for format suggested patients prefer textual as opposed to numerical benefit information. Significant barriers to the acceptance of numerical benefit information included difficulty in understanding the numbers. Patients overestimated the benefits of statins and expressed surprise at the numerical information.
Conclusions: Textual information was preferred but numerical information, in particular in the form of a natural frequency, may help patients make judgements about their medicines. NNTs were found to be very difficult to understand. This raises the prospect that some patients might reject medicines because of disappointment with the perceived low benefits of their medicines. The self-reported impact on behaviour appeared minimal with reports of intentions to 'do what the doctor tells me'. Further research is needed to explore the impact of such statements on people who are yet to be prescribed a statin.
Keywords: medicines information; patient information; risk benefit communication; risk format.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Conflict of interest statement
Conflicts of Interest: None declared.
References
-
- Medicines and Healthcare Products Regulatory Agency. Best practice guidance on patient information leaflets. London: Medicines and Healthcare products Regulatory Agency, 2012.
-
- Co-ordination Group for Mutual Recognition and Decentralized Procedures—Human. CMDh annotated QRD template for MC/DC procedures (based on version 8 of the QRD template for CP), 2011. http://www.hma.eu/uploa
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical